Recent Quotes (30 days)

You have no recent quotes
chg | %

Vigil Health Solutions Inc  

(Public, CVE:VGL)   Watch this stock  
Find more results for VGL
0.000 (0.00%)
Sep 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 1.32
Open     -
Vol / Avg. 0.00/26,829.00
Mkt cap 14.13M
P/E 7.92
Div/yield     -
EPS 0.10
Shares 17.33M
Beta 0.18
Inst. own     -
Nov 15, 2017
Q2 2018 Vigil Health Solutions Inc Earnings Release (Estimated) Add to calendar
Aug 15, 2017
Q1 2018 Vigil Health Solutions Inc Earnings Release

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 3.22% 30.68%
Operating margin 7.67% 13.92%
EBITD margin - 14.34%
Return on average assets 3.49% 47.57%
Return on average equity 5.25% 81.37%
CDP Score - -


2102-4464 Markham St
+1-250-3836900 (Phone)
+1-250-3836999 (Fax)

Website links


Vigil Health Solutions Inc. is a Canada-based company, which is engaged in the development, marketing and distribution of a hardware and software solution for developing care plans and monitoring the aged and dementia sufferers in long-term care facilities. The Company develops and markets the Vigil Integrated Care Management System (the Vigil System) technology platform. Its technology platform combines software and hardware to provide solutions that guide care of and monitor residents living in senior living communities. The Company's product range includes wireless Vitality Care System featuring discreet mini pendants, a nurse call system, mobile fall, incontinence monitoring, resident check in and Vigil Memory Care System. The Company is focused on selling a range of different care options, including independent living, assisted living and skilled nursing facilities to the North American senior's housing market.

Officers and directors

Gregory J. Peet Independent Chairman of the Board
Troy I. Griffiths President, Chief Executive Officer, Director
Nicola Chalmers Chief Financial Officer, Secretary
Jacquie Brennan Vice President - Operations
Steven Smith Vice President - Research & Development
Ian Power Director
Lindsay Ryerson Director